Computational model for predicting CRISPR editing effects
This technology is a machine learning model that can predict post-CRISPR gene expression in human cell types.
Unmet Need: Tool to predict gene expression changes as a function of gene editing in human cells
CRISPR is a technology that enables researchers to edit parts of the genome by removing, adding, or mutating sections of DNA. Although a powerful tool, CRISPR experiments are labor-intensive and often confounded by environmental factors, making probing gene expression effects a difficult process that may not yield scalable results. There is a need for tools and methods that can improve the efficiency and scalability of genetic research using CRISPR.
The Technology: Computational pipeline to predict expression after gene editing
This technology describes a computational pipeline that predicts gene expression data in human cell types. The model is trained from published human single-cell multi-omics data and accurately predicts gene expression in that cell type from chromatin accessibility data. The ability to perform in silico CRISPR enables a more effective strategy for choosing how to edit the genome in both research and therapeutic applications.
Applications:
- CRISPR-based therapy response prediction
- In silico perturbation of regulatory elements
- Non-coding mutation effect evaluation
- Enhancer-promoter target prediction
- Transcription factor interaction analysis
- Generation of databases of gene editing sites
Advantages:
- Trained with reliable, rich multi-omics data sets
- Enables in silico CRISPR
- Data-driven prediction model
- Cost-effective CRISPR target selection
Lead Inventor:
Patent Information:
Patent Pending(WO2024178321)
Related Publications:
Tech Ventures Reference:
IR CU23168
Licensing Contact: Joan Martinez
